{
    "nct_id": "NCT03647358",
    "official_title": "Lesion Dosimetry with Iodine-124 in Metastatic Thyroid Carcinoma",
    "inclusion_criteria": "* Adults with thyroid carcinoma confirmed by pathology.\n* Adult thyroid carcinoma patients who have undergone total thyroidectomy\n* Adult thyroid carcinoma patients have metastatic disease or suspicion for metastatic disease, or are under a protocol intended to explore re-induction therapy for 131I uptake, and are about to undergo Thyrogen-assisted dosimetry, unless Thyrogen-assisted dosimetry is not required per standard of care.\n* The patient and physician are planning to administer 131I for therapy if persistent radioiodine-avid metastases are present.\n* All subjects must have measurable disease, documented within the previous six months by ultrasonography (US), MRI, FDG PET/CT, or CT scanning.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Age less than 18 years.\n* Patients who are pregnant.",
    "miscellaneous_criteria": ""
}